2025 Ketamine Practitioner Intelligence Research Report
What are ketamine practitioner's biggest pain points? Our 2025 Ketamine Practitioner Intelligence Research Report breaks it down.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
What are ketamine practitioner's biggest pain points? Our 2025 Ketamine Practitioner Intelligence Research Report breaks it down.
Read More
Texas has taken a bold step in mental health research by allocating $50 million to fund clinical trials of ibogaine.
Read More
This trial marks a significant departure and may reshape how clinicians combine traditional antidepressants and psychedelic therapy.
Read More
A new study from Stanford University has uncovered unexpected results about ketamine’s role in treating depression.
Read More
The Australian government has announced that Spravato will be added to the Pharmaceutical Benefits Scheme starting July 1.
Read More
As conventional treatments reach their limits for people with advanced cancer, a growing number are turning to psychedelic-assisted therapy.
Read More
In the first study of its kind, nearly 600 individuals shared how psychedelics impact intimacy and sexual expression.
Read More
A federal judge has ordered Utah police to return psychedelic mushrooms they seized from members of a religious group.
Read More
This white paper outlines the current, challenges, and potential solutions for incorporating psychedelics into mainstream medical practice.
Read More
In a groundbreaking study, MDMA may have provided psychological protection to survivors of the Nova music festival.
Read More